GUTS vs. SGHT, TMCI, TLSI, TCMD, INO, LUNG, UTMD, ANGO, CERS, and NPCE
Should you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Sight Sciences (SGHT), Treace Medical Concepts (TMCI), TriSalus Life Sciences (TLSI), Tactile Systems Technology (TCMD), Inovio Pharmaceuticals (INO), Pulmonx (LUNG), Utah Medical Products (UTMD), AngioDynamics (ANGO), Cerus (CERS), and NeuroPace (NPCE). These companies are all part of the "surgical & medical instruments" industry.
Fractyl Health (NASDAQ:GUTS) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, community ranking, risk, media sentiment and profitability.
55.5% of Sight Sciences shares are held by institutional investors. 27.1% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, Fractyl Health had 12 more articles in the media than Sight Sciences. MarketBeat recorded 13 mentions for Fractyl Health and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.89 beat Fractyl Health's score of 0.21 indicating that Sight Sciences is being referred to more favorably in the news media.
Sight Sciences received 12 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 31.91% of users gave Sight Sciences an outperform vote.
Fractyl Health currently has a consensus target price of $22.00, indicating a potential upside of 207.69%. Sight Sciences has a consensus target price of $4.70, indicating a potential downside of 15.32%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than Sight Sciences.
Sight Sciences has higher revenue and earnings than Fractyl Health.
Fractyl Health has a net margin of 0.00% compared to Sight Sciences' net margin of -67.18%. Fractyl Health's return on equity of 0.00% beat Sight Sciences' return on equity.
Summary
Fractyl Health beats Sight Sciences on 9 of the 15 factors compared between the two stocks.
Get Fractyl Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fractyl Health Competitors List
Related Companies and Tools
